A 4-year non-randomized comparative phase-IV study of early rheumatoid arthritis: integrative anthroposophic medicine for patients with preference against DMARDs versus conventional therapy including DMARDs for patients without preference

Harald J Hamre1 Institute for Applied Epistemology and Medical Methodology at the Witten/Herdecke University, Freiburg, GermanyCorrespondence[email protected]

Van N Pham2 Institute of Statistics in Medicine, Universitätsklinikum Düsseldorf, Düsseldorf, Germany

Christian Kern3 Department of Integrative Medicine, Asklepios Westklinikum, Hamburg, Germany

Rolf Rau4 Department of Rheumatology, Evangelisches Fachkrankenhaus Ratingen, Ratingen, Germany

Jörn Klasen3 Department of Integrative Medicine, Asklepios Westklinikum, Hamburg, Germany

Ute Schendel5 Department of Rheumatology, m&i-Fachklinik Bad Pyrmont, Bad Pyrmont, Germany

Lars Gerlach6 Department of Internal Medicine and Gastroenterology, Filderklinik, Filderstadt, Germany

Attyla Drabik2 Institute of Statistics in Medicine, Universitätsklinikum Düsseldorf, Düsseldorf, Germany

Ludger Simon6 Department of Internal Medicine and Gastroenterology, Filderklinik, Filderstadt, Germany

show all

A 4-year non-randomized comparative phase-IV study of early rheumatoid arthritis: integrative anthroposophic medicine for patients with preference against DMARDs versus conventional therapy including DMARDs for patients without preference

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A 4-year non-randomized comparative phase-IV study of early rheumatoid arthritis: integrative anthroposophic medicine for patients with preference against DMARDs versus conventional therapy including DMARDs for patients without preference

Reprints and Permissions

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date